Navigation Links
Nerve Conduction Studies Safe for Patients with Implanted Cardiac Devices

Patients with implanted cardiac devices and their physicians sometimes defer important electrodiagnostic testing because of anxiety about potential negative effects// the testing may have on the device. Good news for these patients and physicians is that according to recent research, electrodiagnostic testing was found to pose minimal or no risk to patients with implanted cardiac devices such as permanent pacemakers and implanted cardiac defibrillators.

Nerve conduction studies (NCSs) are done to detect and evaluate damage to the peripheral nervous system, which includes all the nerves that lead away from the brain and spinal cord and the smaller nerves that branch out from those nerves. Nerve conduction studies are often used to help diagnose nerve disorders, such as carpal tunnel syndrome or Guillain-Barre syndrome, and find the location of abnormal sensations, such as numbness, tingling, or pain.

The prevailing view among electrodiagnostic physicians and cardiac electrophysiologists, is that electrodiagnostic testing on patients with implanted cardiac devices is safe as long as the electrical stimulation is not given in direct proximity to the pulse generator of the cardiac device. Recording from intracardiac sensing electrodes during NCSs, which has not been previously reported, would be the best test to assess safety.

In a recent study, 10 patients with permanent bipolar pacemakers of various makes and 5 patients with implanted cardiac defibrillators (ICD) underwent nerve stimulation at sites commonly used during NCSs. The electrical impulses generated during routine NCSs were never detected by the sensing amplifier of the pacemaker or defibrillators. The NCS did not affect the programmed pacemaker or defibrillator settings and did not cause the defibrillator to discharge. The pacemaker and defibrillator were interrogated before and after NCSs and surface electrocardiogram and atrial and ventricular electrograms were continuo
'"/>




Page: 1 2

Related medicine news :

1. Epilepsy Drug Helps Diabetic Nerve Damage
2. World’s First Nerve Stem Cells Produced
3. Children With Epilepsy Can Be Treated With Nerve Stimulation
4. FDA Approved Nerve-Stimulation Therapy Now Available In New York
5. Doctors Finish Mother-To-Son Nerve Surgery
6. Stem Cells From Hair Follicle To Repair Nerve Damage
7. Nerve regeneration for Spinal cord injuries
8. Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses
9. Dividing Nerve Cells Could Trigger Alzheimers Disease
10. Protein Found to Be Essential For Maintaining Nerve Health
11. Nerve Stimulator for Depression Though Not Effective Was Given Approval
Post Your Comments:
(Date:8/1/2015)... ... August 01, 2015 , ... Calvary Hospital today announced that it is ... campus. The goal is to bring this Torah – dating from 1880 – back ... and religious services. , Scroll No. 515, from the town of Taus-Domazlice, is ...
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of the network ... their Healthy Home mission with the HOPE Movement of EvolvHealth. In what has been ... companies have agreed to join their missions of purpose together to change the course ...
(Date:8/1/2015)... , ... August 01, 2015 , ... On Tuesday, July ... , who are thought to have been behind the attack on Anthem Inc. which ... were zero day exploits, watering hole attacks and spear phishing campaigns. , ...
(Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe ... the very first small business donation to kick off the campaign for healing and ... Her legacy includes a complete line of raw, organic hair care products, as well ...
(Date:8/1/2015)... ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – the Executive Director of ... Appalachian Trail by stepping off Springer Mountain and heading north. Since that day, Phil ... reached Connecticut and was greeted by friends and family. He visited CCAR and left ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:March4thforWellBeing Foundation Kickoff 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2
... begun full-parity plans ahead of deadline; new case studies ... reports the majority of its customers are revamping their ... Act, and that a significant amount already have gone ... 1, 2010. ComPsych Corporation is the world,s largest provider ...
... University of Leeds are working on a new type of body ... cement with recycled carbon fibre materials to make a material tough ... project, still at the early research stage, is being carried out ... Philip Purnell, who is leading the team, said: "By using cement ...
... Improves Patient Care with Automatic Access to Radiology Reports ... a division of Conceptual MindWorks, Inc. (CMI), today announced ... Radiological Association,s (ARA) radiology reports. ARA is one of ... operates 14 outpatient radiology clinics in addition to providing ...
... Innovative new concept caters to active baby-boomer retirees , ... of America (ORCA) has started taking reservations for a program ... private residential cruise ship that also provides both the Independent ... , "People retire to Florida for three things mainly ...
... , CHICAGO, June 29 Rising Financial ... of Rising Medical Solutions, Inc., is pleased to announce ... Business Development for its Medicare Set Aside (MSA) Administration ... , , Abdelsayed joins Rising Financial Solutions (Rising) ...
... , Italy, June 29 Health-Robotics today announced,that ... with Grifols,S.A., the leading Pharmacy Automation provider in ... accurately, and cost-effectively automate,the preparation of non-hazardous IV ... this strategic partnership, Grifols will take,delivery of 120 ...
Cached Medicine News:Health News:Mental Health Parity Act Spurs Early Action Among Employers 2Health News:Sevocity Launches EHR (Electronic Health Record) Interface With Austin Radiological Association 2Health News:Sevocity Launches EHR (Electronic Health Record) Interface With Austin Radiological Association 3Health News:Retirement Cruise Ship Nearing Launch 2Health News:Rising Financial Solutions Taps Director of Business Development for Medicare Set Aside Administration Offerings 2Health News:Health Robotics Announces i.v.STATION(TM) Contract With Grifols in Spain, Portugal and South America 2Health News:Health Robotics Announces i.v.STATION(TM) Contract With Grifols in Spain, Portugal and South America 3
(Date:7/31/2015)... SAN DIEGO , July 31, 2015 ... Eisai Co., Ltd. (Headquarters: Tokyo , ... Halozyme Therapeutics, Inc. (Headquarters: San Diego, California ... , "NASDAQ: HALO") have signed a clinical collaboration agreement ... , "eribulin") in combination with Halozyme,s investigational drug PEGPH20 ...
(Date:7/30/2015)... Mettler-Toledo International Inc. (NYSE: MTD ) ... are the highlights: , Sales in local ... prior year. Reported sales decreased 4% as currency reduced ... Net earnings per diluted share as reported (EPS) were ... EPS was $2.80 , an increase of 9% ...
(Date:7/30/2015)...  EP Global Communications, Inc. (Public OTC: EPGL) announced today ... Company about discussing EPGL,s electronic contact lens technologies.  ... 3, 2015.  Novartis CEO Joe Jimenez ... electronic contact lens market could be worth tens ... years.  Novartis partnered with Google in 2014 to ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14
... RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm ... it has acquired a majority interest in Salter Labs ... a leading manufacturer of disposable respiratory and sleep diagnostics ... care markets.   "Salter represents an exciting ...
... Talecris Biotherapeutics (Nasdaq: TLCR ) announced ... Inhibitor [Human])(A1PI), a more concentrated and purified formulation of ... Canada for more than 20 years.  PROLASTIN-C delivers twice ... infusion volume and time in half when given at ...
Cached Medicine Technology:RoundTable Healthcare Partners Acquires Majority Stake in Salter Labs 2RoundTable Healthcare Partners Acquires Majority Stake in Salter Labs 3Talecris Biotherapeutics Launches PROLASTIN®-C in Canada 2Talecris Biotherapeutics Launches PROLASTIN®-C in Canada 3Talecris Biotherapeutics Launches PROLASTIN®-C in Canada 4Talecris Biotherapeutics Launches PROLASTIN®-C in Canada 5
... Nephew ECTRA II systems permit the surgeon ... ligament endoscopically, allowing access via two portals ... endoscopic lens fogging with good air flow. ... and control. ECTRA knives permit the surgeon ...
... Screw System provides a unique option for the ... particularly the opening wedge osteotomy of the first ... Fragment Plate and Screw Set is a complete ... houses the plates, screws, and drills. It provides ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Medicine Products: